| Send2Press.com • Today is Monday, February 13, 2012 | A Member of the Neotrope News Network |  |
|
|
NEWS ARCHIVES : U.S. and World News :
Medical :
Devices and Research
News
|
Press Release:
Compelling Clinical Data Proves VitalStim Therapy Offers Relief from Dysphagia and Swallowing Difficulty
SEATTLE, Wash., March 3 (SEND2PRESS NEWSWIRE) -- VitalStim® Therapy is a patented-therapy process and equipment system developed specifically to treat dysphagia and patients with difficulty swallowing. And, it's safe and effective. Developed by Marcy L. Freed, MA, CCC-SLP, in response to reports that approximately 15 million Americans live with dysphagia, VitalStim Therapy is a non-invasive, external electrical stimulation therapy cleared to market, in December 2002, by the Food and Drug Administration (FDA). And, it's the only Neuromuscular Electrical Stimulation (NMES) therapy that has received such FDA clearance for dysphagia. VitalStim Therapy, backed by comprehensive data from 892 clincial patient trials, applies specifically-designed electrodes to the muscles of the throat to promote proper swallowing. It does this through muscle re-education. Designed as an adjunct therapy, VitalStim Therapy works together with swallowing-related exercises. Through various studies, it has demonstrated its ability to yield positive results. In a three-year follow-up study, VitalStim Therapy was proven to accelerate recovery time from a restricted diet and also helped patients to achieve sustained improvement and long-term results. Most recently, a second published study demonstrated the lasting positive impact of VitalStim Therapy in a group of patients who had experienced failed dysphagia therapy. To date, VitalStim Therapy has been referenced in a best-selling, self-help book on stroke recovery. Articles have appeared in numerous publications such as The Boston Globe and The Los Angeles Times in addition to many hospital and health care reports. About the Founder: Marcy L. Freed, MA, CCC-SLP, founder of VitalStim Technologies LLC, has changed the face of dysphagia therapy through this medical breakthrough approach that combines traditional dysphagia therapy with NMES. With 32 years of experience, Freed specializes in voice and swallowing intervention and is currently a speech-language pathologist with the University Hospital of Cleveland. For more information, visit: www.VitalStim.com.
NEWS SOURCE: VitalStim, LLC
Send2Press® is the originating wire service for this story. Terms of Use. © VitalStim, LLC. All trademarks acknowledged.
THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE (VitalStim, LLC), WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE.
Journalist Resources:
Download original press release as issued including media contact information for VitalStim, LLC.
Additional News Releases on Similar Topics:
|
Subscribe to Send2Press®
Daily News Releases by E-Mail
Follow Send2Press on Social Sites: 
Additional News from
VitalStim, LLC :
|
||||||||||||||||||||||||||
View our news channels by industry topics, by U.S. States, or by selected U.S. Cities:
|
Terms of Use and License
This "article format" version of the issued press release is Copr. © 1983-2012 Neotrope/Send2Press. You may freely link to this article version of the press release or may use the release text as the basis for an original article or news posting. If the content is copied verbatim via a scraping or copy/paste method, the news item must be properly "attributed" to Send2Press® Newswire as the originating wire service for this story (may not be posted on ANY site selling/offering SEO or PR services, newswire services, or adult content!). |
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the source. The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this website) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: Compelling Clinical Data Proves VitalStim Therapy Offers Relief from Dysphagia and Swallowing Difficulty, VitalStim Therapy, Marcy L Freed MA CCC-SLP, dysphagia therapy with NMES, medical devices, FDA approved, dysphagia, Neuromuscular, Electrical Stimulation, swallowing function, promote proper swallowing, Seattle business, press release, Mar 3, 2010. |
|
THIS PAGE MEDIA READS (by media and public, as of today): 3284 times (1 today, 3 this week, 27 this month, 99 this year)
Site Design and Content is Copr. © 1983 - 2011 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Our Services | Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Journalist Tools | Client eMediaKits | Headline Feeds | Podcast | PR News Channels | Daily News Desk | Success Stories | PRTRax™ Reader Tracking | Targeted News Distribution | Internet Marketing Services | Order PR Services | Terms of Service (TOS)